Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life

BACKGROUND: Treatment efficacy and costs of anti-VEGF drugs have not been studied in clinical routine. OBJECTIVE: To compare treatment costs and clinical outcomes of the medications when adjusting for patients’ characteristics and clinical status. DESIGN: Comparative study. SETTING: The largest publ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Schmid, Martin K., Reich, Oliver, Faes, Livia, Boehni, Sophie C., Bittner, Mario, Howell, Jeremy P., Thiel, Michael A., Signorell, Andri, Bachmann, Lucas M.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524713/
https://ncbi.nlm.nih.gov/pubmed/26241852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0135050
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars